Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01721577
Title Phase I/II Trial of Safety and Anti-tumor Efficacy of AXL1717(Picropodophyllin) in the Treatment of Recurrent Malignant Astrocytomas
Acronym AXL1717
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Rush University Medical Center
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Rush University Medical Center Chicago Illinois 60612 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field